ZA944687B - Mammamodulin a hormone-independent mammaru tumor cell specific protein - Google Patents

Mammamodulin a hormone-independent mammaru tumor cell specific protein

Info

Publication number
ZA944687B
ZA944687B ZA944687A ZA944687A ZA944687B ZA 944687 B ZA944687 B ZA 944687B ZA 944687 A ZA944687 A ZA 944687A ZA 944687 A ZA944687 A ZA 944687A ZA 944687 B ZA944687 B ZA 944687B
Authority
ZA
South Africa
Prior art keywords
mammaru
mammamodulin
hormone
independent
tumor cell
Prior art date
Application number
ZA944687A
Inventor
Urs Eppenberg
Willi Kueng
Hanno Langen
Ernst-Juergen Schlaeger
Karl Weyer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA944687B publication Critical patent/ZA944687B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/4756Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA944687A 1993-07-06 1994-06-29 Mammamodulin a hormone-independent mammaru tumor cell specific protein ZA944687B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93110756 1993-07-06

Publications (1)

Publication Number Publication Date
ZA944687B true ZA944687B (en) 1995-02-24

Family

ID=8213047

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA944687A ZA944687B (en) 1993-07-06 1994-06-29 Mammamodulin a hormone-independent mammaru tumor cell specific protein

Country Status (9)

Country Link
EP (1) EP0659212A1 (en)
JP (1) JPH08501456A (en)
CN (1) CN1111910A (en)
AU (1) AU7185894A (en)
CA (1) CA2141417A1 (en)
NZ (1) NZ268592A (en)
RU (1) RU95116901A (en)
WO (1) WO1995002052A1 (en)
ZA (1) ZA944687B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69732711T2 (en) 1996-07-12 2006-03-16 Genentech, Inc., South San Francisco GAMMA-heregulin
AU4469997A (en) * 1997-09-17 1999-04-05 Urs Eppenberger Heregulin-gamma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79255A0 (en) * 1986-06-26 1986-09-30 Hadassah Med Org Composition for metastasis prevention
US5158893A (en) * 1986-12-11 1992-10-27 Peralta Cancer Research Institute Methods and compositions for screening carcinomas
IL101943A0 (en) * 1991-05-24 1992-12-30 Genentech Inc Structure,production and use of heregulin

Also Published As

Publication number Publication date
JPH08501456A (en) 1996-02-20
NZ268592A (en) 1996-09-25
AU7185894A (en) 1995-02-06
RU95116901A (en) 1997-03-27
EP0659212A1 (en) 1995-06-28
WO1995002052A1 (en) 1995-01-19
CN1111910A (en) 1995-11-15
CA2141417A1 (en) 1995-01-19

Similar Documents

Publication Publication Date Title
GB9326450D0 (en) Binding assay
EP0852627A4 (en) Cell death protein
GB9225453D0 (en) Binding proteins
IL108169A0 (en) New peptides
AU4244793A (en) Human cell cycle checkpoint genes
GB9326451D0 (en) Binding assay
ZA895137B (en) Novel peptides
GB9306742D0 (en) Electrochemical assay
AU106495S (en) Carry case
IL108353A0 (en) Novel peptides
EP0719345A4 (en) Reagent
GB8807427D0 (en) Peptides
GB8821077D0 (en) Peptides
ZA944687B (en) Mammamodulin a hormone-independent mammaru tumor cell specific protein
GB8802464D0 (en) Cell
GB8828097D0 (en) Peptides
ZA899168B (en) Peptides
GB9621492D0 (en) Novel cell surface protein compounds
GB9319969D0 (en) Binding proteins iv
GB9311462D0 (en) Dry cell recharger
KR0160403B1 (en) Dna encoding novel cell surface protein
GB9313070D0 (en) Binding protein
GB9306945D0 (en) Cell modification
IE882173L (en) Peptides
IE881990L (en) Peptides